Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The colonic epithelial cell cytoskeleton is the complex internal scaffolding of epithelial cells lining the colon, consisting primarily of actin filaments, microtubules, and intermediate filaments, along with a host of regulatory proteins such as villin, ezrin, and others[2][6]. This cytoskeletal network not only supports cell shape and polarization[7], but also plays crucial roles in the formation and maintenance of cell-cell junctions (tight junctions, adherens junctions), barrier integrity[5], cell migration and wound healing, and cellular responses to inflammation and infection[2][4]. Alterations in the organization or regulation of the epithelial cytoskeleton are implicated in diseases such as inflammatory bowel disease and colorectal cancer. Although certain agents can target specific cytoskeletal proteins, the “colonic epithelial cell cytoskeleton” itself is not an individual molecular drug target, but a dynamic system essential for epithelial homeostasis. The cytoskeleton regulates epithelial barrier function, is remodeled during disease and healing, and plays critical roles in cell adhesion and migration[5][2]. Its components are involved in junctional organization (e.g., actin links to tight and adherens junctions via proteins like ZO-1 and E-cadherin/β-catenin complexes)[5][6]. Remodeling is especially noted during infection and immune-mediated damage but is not selectively druggable as a single “receptor” or molecule[2][6]. This is not a canonical therapeutic target, but rather a cell structural system comprising many druggable molecular components. Specification to a single component (e.g., "ezrin," "villin," "E-cadherin") is required for structured pharmacological or physiological data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic epithelial cell cytoskeleton.